深度学习在动脉自旋标记中检测卒中半暗带
本研究开发并评估基于三维伪连续动脉自旋标记(pCASL)的深度学习算法,用于辅助筛选适合血管内治疗的急性缺血性卒中患者。使用137例患者共167组pCASL数据训练神经网络,以动态磁敏感对比磁共振成像生成的低灌注区域为标签,并与6种机器学习算法比较。深度学习算法在体素级AUC达0.958,受试者级治疗资格判断准确率92%,在GE设备数据上外部验证AUC为0.94、准确率92%。
要点
- 基于pCASL的深度学习算法可预测低灌注区域,体素级AUC为0.958。
- 判断血管内治疗资格的准确率92%,敏感度0.89,特异度0.95。
- 在GE设备数据上外部验证AUC 0.94,准确率92%,无需参数微调。
核心结论
- pCASL联合深度学习算法有望辅助急性缺血性卒中血管内治疗决策。
研究设计与样本
- 回顾性研究,纳入137例急性缺血性卒中患者的167组三维pCASL数据训练神经网络。
- 以同步采集的动态磁敏感对比磁共振成像生成的低灌注区域为标签。
- 深度学习与6种机器学习算法采用10折交叉验证训练。
- 治疗资格依据DEFUSE 3试验的灌注/弥散不匹配标准回顾性判定。
主要发现
- 深度学习算法预测动态磁敏感对比定义的低灌注区域,体素级AUC为0.958。
- 6种机器学习算法的体素级AUC范围为0.897至0.933。
- 深度学习算法判断受试者级血管内治疗资格的准确率为92%,敏感度0.89,特异度0.95。
- 在GE pCASL数据上,深度学习算法体素级AUC为0.94,受试者级准确率为92%。
关键数值与推荐
- 血管内治疗资格判定采用DEFUSE 3试验的灌注/弥散不匹配标准。
- 深度学习算法体素级AUC 0.958,受试者级准确率92%、敏感度0.89、特异度0.95。
- 外部验证体素级AUC 0.94,受试者级准确率92%。
临床怎么用
- pCASL无需对比剂注射,深度学习算法可辅助筛选适合血管内治疗的卒中患者。
- 算法在GE设备数据上无需微调即达92%准确率,显示一定泛化能力。
局限性
- 回顾性研究,治疗资格基于DEFUSE 3标准回顾性判定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Selection of patients with acute ischemic stroke for endovascular treatment generally relies on dynamic susceptibility contrast magnetic resonance imaging or computed tomography perfusion. Dynamic susceptibility contrast magnetic resonance imaging requires injection of contrast, whereas computed tomography perfusion requires high doses of ionizing radiation. The purpose of this work was to develop and evaluate a deep learning (DL)-based algorithm for assisting the selection of suitable patients with acute ischemic stroke for endovascular treatment based on 3-dimensional pseudo-continuous arterial spin labeling (pCASL). Methods- A total of 167 image sets of 3-dimensional pCASL data from 137 patients with acute ischemic stroke scanned on 1.5T and 3.0T Siemens MR systems were included for neural network training. The concurrently acquired dynamic susceptibility contrast magnetic resonance imaging was used to produce labels of hypoperfused brain regions, analyzed using commercial software. The DL and 6 machine learning (ML) algorithms were trained with 10-fold cross-validation. The eligibility for endovascular treatment was determined retrospectively based on the criteria of perfusion/diffusion mismatch in the DEFUSE 3 trial (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke). The trained DL algorithm was further applied on twelve 3-dimensional pCASL data sets acquired on 1.5T and 3T General Electric MR systems, without fine-tuning of parameters. Results- The DL algorithm can predict the dynamic susceptibility contrast-defined hypoperfusion region in pCASL with a voxel-wise area under the curve of 0.958, while the 6 ML algorithms ranged from 0.897 to 0.933. For retrospective determination for subject-level endovascular treatment eligibility, the DL algorithm achieved an accuracy of 92%, with a sensitivity of 0.89 and specificity of 0.95. When applied to the GE pCASL data, the DL algorithm achieved a voxel-wise area under the curve of 0.94 and a subject-level accuracy of 92% for endovascular treatment eligibility. Conclusions- pCASL perfusion magnetic resonance imaging in conjunction with the DL algorithm provides a promising approach for assisting decision-making for endovascular treatment in patients with acute ischemic stroke.
引用
- Wang K, Shou Q, Ma SJ, et al. Deep Learning Detection of Penumbral Tissue on Arterial Spin Labeling in Stroke. Stroke. 2019. PMID: 31884904. doi:10.1161/STROKEAHA.119.027457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。